Electric school buses may yield significant h
eurekalert.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eurekalert.org Daily Mail and Mail on Sunday newspapers.
Warning labels have become far too common to be taken seriously by consumers – NaturalNews com
naturalnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from naturalnews.com Daily Mail and Mail on Sunday newspapers.
Herndon, Va. (May 20, 2021) - The international journal
Risk Analysis has published a timely special issue for May 2021, Global Systemic Risk and Resilience for Novel Coronavirus and COVID-19. Featuring 11 papers written for this issue over the past year, the collection represents a sampling of insights and viewpoints from scholars across risk sciences and resilience analytics to guide decision-making and operations related to the COVID-19 pandemic.
The 11 papers address the breadth of risk sciences represented by the Society for Risk Analysis (SRA), including risk perception, risk and resilience, human health and infection risk, and risk management strategies and economic evaluation. From a systems perspective, the multidisciplinary expertise of the SRA and its specialty groups can offer new tools for public health practitioners, infrastructure owners/operators, and policymakers to coordinate global and local, context-specific interventions, with expanded access to health info
Mohammad S. Jalali â the principal investigator for a joint simulation modeling project between Harvard researchers and the Food and Drug Administration â presented his labâs ongoing efforts to accurately model the opioid crisis during a Harvard School of Public Health seminar on Tuesday.
Hosted by the Center for Health Decision Science, the event outlined existing research on opioid usage in America, the modelâs development, and tentative results. Health policy professor Joseph S. Pliskin and senior research scientist Lisa A. Robinson served as moderators.
Due to agreements with the FDA, however, the modelâs results must remain confidential to the public until publication in roughly four months, according to Jalali.